This might be useful in cancer immunotherapy since it prevents cancer cells from escaping immunosurveillance, as NLRC5 is boosted in SKBR3 BC cells by IFN-γ along with overexpression in MHC-I (HLA-ABC) expression (158). The gene discussed is IFNG; the disease is breast cancer.